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A b s t r a c t
The overall prevalence of symptomatic heart failure (HF) is similar in men and women and constitutes about a quarter of the 
first manifestation of cardiovascular disease in both sexes. However, there is an important difference between the sexes in the 
type of HF. Whereas men more frequently develop HF with reduced ejection fraction, HF with preserved ejection fraction is 
especially frequent in women. The major risk factors for symptomatic HF are high blood pressure and arterial stiffness, which 
evoke a complex network of functional and structural changes in the heart in both men and women. In this review, we will 
discuss the recent epidemiological data on sex discrepancies in cardiac maladaptation to hypertension and arterial stiffening. 
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EPIDEMIOLOGY OF SYMPTOMATIC  
HEART FAILURE
The major burden of symptomatic heart failure (HF) on public 
health and national healthcare systems highlights the pressing 
need for better diagnosis and management of this disorder 
[1, 2]. Currently, symptomatic HF affects nearly 15 million 
Europeans [3] and its prevalence is expected to increase over 
the next decades due to extending life expectancy and rising 
presence of risk factors such as hypertension and diabetes mel-
litus [1]. Moreover, in recent years, the actual burden of HF has 
exceeded the one predicted by the American Heart Association 
[4, 5]. At the age of 40 years, the lifetime risk of developing 
HF is approximately one in five, in both men and women [6]. 
While traditionally associated with the concept of pump 
failure or reduced left ventricular (LV) ejection fraction (EF), 
it has become widely recognised that HF can occur even 
when EF is preserved, constituting the syndrome of HF 
with preserved EF (HFpEF) [7]. Symptomatic HF has a poor 
prognosis, regardless of whether EF is reduced or not [8–10]. 
For instance, a recent meta-analysis of 41,972 HF patients 
reported 121 deaths per 1000 patient-years in those with 
HFpEF and 141 deaths per 1000 patient-years in those with 
HF with reduced EF (HFrEF) [10]. 
In comparison to patients with HFrEF, those with HFpEF 
are typically older, are more often women, and have a history 
of hypertension (Fig. 1) [10, 11]. The sex discrepancy in the 
prevalence of HFrEF and HFpEF might originate from differ-
ences in the major risk factors for HF in men and women. 
Indeed, whereas men more frequently develop HFrEF as 
a complication of coronary heart disease, HFpEF is especially 
frequent in women with risk factors such as hypertension, 
obesity, and diabetes [10, 11]. Of note, HFpEF is often under-
diagnosed in elderly women even if it is already symptomatic. 
Moreover, due to diagnostic difficulties, women have often 
been underrepresented in randomised clinical trials testing 
the effect of treatments on HF, even though this disease often 
affects elderly women.
HYPERTENSION AND ARTERIAL STIFFENING  
AS RISK FACTORS FOR HEART FAILURE
In both men and women, hypertension plays a prominent role 
in the development of symptomatic HF, in particular of HFpEF 
[9, 11]. In the Framingham study, hypertension was observed 
in 75% of new HF cases [6]. According to community-based 
data, hypertension contributes more to development of HF 
in women than in men. For instance, the adjusted risk for HF 
was approximately twofold higher in hypertensive men, but 
threefold higher in hypertensive women as compared to their 
normotensive counterparts [12]. The population-attributable 
risk of hypertension for symptomatic HF was 39% in men 
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and 59% in women (Fig. 2) [12]. Women have lower blood 
pressure (BP) than men during the reproductive years, but not 
in the older age, when HFpEF typically develops [13]. From 
the menopause on, the cardioprotective effects of female sex 
hormones are lost and BP levels start to rise in older women 
and even surpass those of men [13].
In addition, arterial stiffening, a common feature of vas-
cular ageing, might accelerate the development of HF and 
exacerbate its symptoms [14, 15]. Indeed, HF patients have 
greater aortic stiffness than healthy controls [16]. Moreover, 
even asymptomatic subjects with higher arterial stiffness as 
assessed by aortic pulse wave velocity (PWV) were found to 
exhibit a higher risk for all-cause death, [17] cardiovascular 
events [17, 18], and symptomatic HF [19] beyond traditional 
cardiovascular risk factors. For instance, one standard devia-
tion increase in aortic PWV was associated with a 29% higher 
adjusted risk for incident symptomatic HF [19]. To date, no 
prospective population study has reached sufficient statistical 
power to study the independent predictive value of arterial 
stiffness for the development of HF separately in women and 
men. For instance, Tsao et al. [19] did not find a significant 
interaction between arterial stiffness and sex for HF incidence, 
but their sex-specific analysis has been questioned due to the 
low number of events per group [20]. Future studies will need 
Figure 1. Sex differences in the prevalence of heart failure with reduced ejection fraction (HFrEF) (A) or preserved ejection fraction 
(HFpEF) (B). Age- and sex-specific prevalence of HFrEF and HFpEF in a general population cohort from southwest Europe.  
Prevalence of HFrEF and HFpEF increased with age in both sexes. HFrEF was more prevalent in men and HFpEF more prevalent  
in women at any given age. Reproduced from Ceia F et al. [88] with permission
Figure 2. Population-attributable risk for the development of congestive heart failure in 5143 Framingham Study participants by 
sex; A. Men; B. Women. The population-attributable risk of hypertension (HT) for congestive heart failure was 39% in men and 
59% in women; AP — angina pectoris; DM — diabetes mellitus; LVH — left ventricular hypertrophy; MI — myocardial infarction; 
VHD — valvular heart disease. Reproduced from Levy et al. [12] with permission
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to be larger and with long-term follow-up, in order to include 
a higher number of incident HF events that will have to be 
dichotomised by sex and by type of HF.
Because of the risk factors such as hypertension, arterial 
stiffness, insulin resistance, and myocardial ischaemia, the LV 
progressively remodels [21, 22] and its systolic and diastolic 
functions gradually worsen [23–25] years to decades before 
HF symptoms present. Using echocardiography, the non-in-
vasive and easily accessible technique for the assessment of 
cardiac structure and function, subclinical LV maladaptation 
was observed in subjects free from HF symptoms, but with 
cardiovascular risk factors [21, 23, 24, 26, 27]. Indeed, in 
patients with hypertension and increased arterial stiffening, 
LV afterload is chronically elevated, opposing LV ejection, and 
the heart is forced to work at a high performance level [28]. 
In the long run, the chronic rise in LV workload will increase 
the heart’s energy expenditure and oxygen consumption 
and trigger asymptomatic yet adverse myocardial remodel-
ling and dysfunction [16, 29]. Over time, these adverse LV 
changes gradually diminish the cardiac reserve, until they 
evoke HF symptoms, disability, and death [16, 29]. Within 
this context, better understanding and targeting of the risk 
factors for early subclinical LV remodelling and dysfunction 
(e.g. hypertension, arterial stiffening, etc.) may be the most 
cost-effective strategy to reduce the burden of symptomatic 
HF on our society [30]. 
SEX-SPECIFIC CARDIAC MALADAPTATION TO 
HYPERTENSION AND ARTERIAL STIFFENING
LV remodelling
To better understand cardiac remodelling induced by 
hypertension and arterial stiffening, one should consider 
the law of Laplace, describing the relationship between 
LV pressure, volume, and wall stress. According to this 
equation, LV wall stress is directly proportional to the LV 
pressure and internal radius, and inversely proportional to 
its wall thickness. Higher pressure can cause thickening of 
LV walls to accommodate an increased load and maintain 
normal wall tension. Indeed, patients with hypertensive 
heart disease usually present with concentric (inward) LV 
remodelling and/or hypertrophy. On the other hand, LV 
chamber volumes and EF could be preserved for a longer 
time in such patients [31]. Of note, under hypertensive 
conditions, women are more likely to present LV concentric 
remodelling/hypertrophy, whereas men more commonly 
develop eccentric LV hypertrophy (LVH) [32, 33].
Previous population studies reported cross-sectional and 
longitudinal associations of LV remodelling with hypertension 
and arterial stiffness. In the Framingham study, exposure to 
elevated BP at baseline was associated with future develop-
ment of LVH as assessed by echocardiography in both men 
and women [21]. Moreover, in line with a small study in 
100 subjects free of overt cardiac disease [34], a cross-sec-
tional magnetic resonance imaging study in 2093 MESA 
participants showed that higher proximal aortic stiffness was 
associated with LV concentric remodelling [35]. Furthermore, 
in 607 FLEMENGHO participants, in both men and women, 
we observed similar associations of longitudinal increases 
in LV wall thickness and relative wall thickness (a marker of 
concentric remodelling) with higher baseline PWV during 
a five-year follow-up period, independent of other important 
covariables (Fig. 3) [24]. In contrast to a cross-sectional study 
reporting a relation between concentric remodelling and 
arterial stiffness only in postmenopausal women [36], we 
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Figure 3. Arterial stiffness as a mediator of left ventricular concentric remodelling in both men (A) and women (B). In 607 FLE-
MENGHO participants, higher arterial stiffness (PWV) at baseline independently predicted stronger left ventricular concentric 
remodelling (RWT) in both sexes during a five-year follow-up period; LVID — left ventricular internal diameter; PE — parameter 
estimate; PWT — posterior wall thickness; PWV — pulse wave velocity; RWT — relative wall thickness; SD — standard deviation; 
SWT — septal wall thickness; *p < 0.05; **p < 0.01. Reproduced from Cauwenberghs et al. [24] with permission
A B
confirmed the importance of aortic stiffening as a mediator 
of LV concentric remodelling in both men and women [24].
Previous population studies have demonstrated the link be-
tween adverse LV remodelling and future cardiovascular events 
[21, 37]. In a meta-analysis including 48,545 participants from 
20 prospective studies, the presence of LVH implied a 2.3- and 
2.5-fold higher weighted risk for future cardiovascular morbid-
ity and all-cause mortality, respectively [37]. The authors also 
reported a trend toward a worse prognosis among women 
with baseline LVH compared with men [37]. Furthermore, 
in the Framingham Heart Study, developing an abnormal LV 
geometric pattern (concentric remodelling) during four years 
of follow-up was associated with a 1.6 times greater risk for 
developing cardiovascular disease in a subsequent follow-up 
period of 12 years [21]. Several mechanisms may explain why 
adverse LV remodelling and hypertrophy can lead to poor car-
diovascular outcome. First, an abnormal LV geometry can lead 
to diastolic filling disturbances, a harbinger of congestive HF. 
Second, structural LV maladaptation can damage the autonomic 
nervous system, reduce the coronary reserve, and increase the 
oxygen requirements of the heart. Lastly, it increases the risk 
for ventricular arrhythmias and sudden death.
LV diastolic dysfunction
Parallel to cardiac remodelling, LV diastolic function 
progressively worsens throughout life [23]. Diastolic 
dysfunction stands central in the development of HFpEF. 
Conventional echocardiography and tissue Doppler imag-
ing (TDI) allow to detect subclinical deterioration of LV 
diastolic function [38]. Impaired LV myocardial relaxation 
is initially characterised by decreased early (E peak) and 
enhanced late (A peak) diastolic blood velocities over the 
mitral valve as well as by less vigorous mitral annulus mo-
tion (e’ peak) during early diastole. The more advanced 
stage of diastolic dysfunction presents also with increased 
LV filling pressure at end-diastole because of increased 
LV stiffness. Combining the early transmitral flow velocity 
with the early mitral annular TDI velocity (E/e’ ratio) allows 
a non-invasive evaluation of LV filling pressure [39].
Previous population studies demonstrated that LV dias-
tolic function is sensitive to increased central haemodynamics 
and arterial stiffness, particularly in women [24, 40, 41]. For 
instance, in our community-based sample, higher central 
pulse pressure (reflecting aortic compliance) independently 
predicted a stronger increase in LV mass and LV filling pressure 
(E/e’ ratio) during five years of follow-up, but only in women 
(Fig. 4) [24]. This higher sensitivity of LV diastolic function 
of women to increased pulsatile load might be explained 
by the fact that women, as compared to men, present on 
average higher aortic stiffness [40, 42], enhanced LV systolic 
performance [43–45], higher preload sensitivity, and lower 
LV compliance [43]. First, BP, aortic stiffness, and wave re-
flection increase more prominently with age in women than 
in men [44, 46]. Second, women have on average smaller 
heart chamber volumes, even after standardisation for body 
size [44], with higher LVEF [45] and global longitudinal 
deformation (strain) [47], and a steeper slope of the stroke 
work/end-diastolic volume relationship (Starling curve), sug-
gesting overall enhanced LV performance as compared to 
men [44]. Third, the passive LV diastolic elastance, a major 
determinant of LV filling pressure, also appears to be higher 
in women than in men [44, 46]. These observations might 
conjointly explain why HFpEF appears to affect twice as many 
women as men [48–50].
Figure 4. The left ventricular (LV) diastolic function of women is sensitive to increased central haemodynamics and arterial  
stiffness; A. Men; B. Women. In 607 FLEMENGHO participants, higher central pulse pressure (cPP) (reflecting aortic compliance)  
at baseline independently predicted a stronger increase in LV mass and LV filling pressure (E/e’ ratio) in women at five-year 
follow-up examination. LVMI — left ventricular mass index; PE — parameter estimate; SD — standard deviation; *p < 0.05; 
**p < 0.01; ***p < 0.001. Reproduced from Cauwenberghs et al. [24] with permission
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In clinical practice, LV systolic function is often evaluated by 
the fraction of blood that is ejected by the LV during systole 
(i.e. EF). However, reductions in EF seem to appear only late 
in HF development [25, 51], questioning its usefulness in 
detecting early stages of cardiac dysfunction. Instead, changes 
in the relative deformation (or strain) of the LV might better 
reflect preclinical worsening in LV systolic performance [25]. 
The heart is a complex three-dimensional structure with myo-
cytes laid out in different directions. Longitudinal deformation 
of the heart results from the contraction and relaxation of 
longitudinally-stretched subendocardial and subepicardial 
fibres, whereas LV wall thickening along the radial axis mainly 
originates from the contraction of circumferential fibres lo-
cated in the midwall [52]. It should be noted that longitudinal, 
circumferential, and radial strains are not interchangeable and 
might hold different diagnostic and prognostic information 
[53, 54]. Separate analysis of LV deformation along the various 
axes might thus help us to better understand the progression 
of LV systolic dysfunction induced by risk factors [25, 55].
LV longitudinal strain and afterload
The average deformation of the LV in the longitudinal direc-
tion (referred to as LV global longitudinal strain or global LS) 
has been validated as a reproducible and valuable marker of 
LV systolic function that could be more sensitive than EF [25, 
47, 56]. In fact, longitudinal systolic dysfunction is already 
observed in the early stages of myocardial maladaptation 
following a chronically increased load [42, 57]. 
High systemic arterial pressure particularly elevates LV 
wall stress in the endocardium, predominantly consisting 
of longitudinally oriented fibres, and might thus specifically 
burden the long-axis deformation. Theoretical models already 
predicted that longitudinal LV deformation decreases with an 
increase in the mean arterial pressure (MAP) [58]. In line with 
this model, clinical studies demonstrated that hypertensive 
patients had significantly lower LV longitudinal strain than nor-
motensive controls [59–61]. Moreover, in community-based 
cohorts, in both men and women LV longitudinal strain 
declined independently with an increase in the steady BP 
component (i.e. MAP) in continuous analysis [42, 62]. Also, 
several measures of aortic stiffening were associated with 
worse LV longitudinal deformation, even after accounting for 
important confounders. For instance, in a large Framingham 
cohort, lower global LS was independently associated with 
higher aortic pulse wave velocity similarly in both men and 
women [63].
Several community-based studies [47, 64, 65] have dem-
onstrated that low global LS is associated with a greater risk for 
future cardiovascular and cardiac events [47]. For instance, 
FLEMENGHO participants belonging to the lower quartile of 
global LS distribution (i.e. reduced global LS) exhibited a sig-
nificantly higher adjusted risk than the average population 
for future cardiovascular (128%) and cardiac (94%) events 
[47]. Of note, in the Copenhagen City Heart study global LS 
was a stronger prognosticator for incident HF in men than in 
women [64].
LV radial strain and afterload
Overall, LV wall stress is suggested to be higher longitudinally 
than circumferentially due to differences in LV curvature 
[66]. Therefore, an increased afterload might less affect the 
circumferential fibres within the midwall than the longitudinal 
fibres in the subendocardium [57, 66]; an experimental aortic 
banding model showed disparate changes in longitudinal 
and radial deformation in response to an acute increase in 
LV afterload [67]. Whereas longitudinal systolic function de-
creased dramatically, LV radial strain was still preserved upon 
mild aortic banding [67]. Similarly, in both hypertensives and 
diabetics at early stage of disease, decreased LV longitudinal 
deformation was compensated by an increase in LV radial 
function [59–61, 68]. 
Along these lines, we reported an age-dependent re-
lationship of changes in LV radial systolic deformation with 
early and late systolic load in a general population (Fig. 5) [42, 
69]. Radial strain increased significantly with higher central 
pulse pressure, haemodynamic load components, and PWV 
in middle-aged participants only, whereas it decreased with 
these indexes in subjects above 70 years old [42, 69]. Overall, 
a chronic rise in afterload and, in turn, LV load might thus 
enhance the circumferential/radial systolic performance of 
the left ventricle initially as a compensation for the decline in 
longitudinal deformation and might only lead to an impair-
ment of radial (and circumferential) deformation in the long 
run [25]. To date, however, there is a compelling need for 
serial imaging studies in the general population to clarify to 
what extent a long-term LV overload, e.g. due to hypertension 
and arterial stiffening, contributes to subclinical impairment of 
the different LV strain components and whether this happens 
in a sex-dependent way.
ANTIHYPERTENSIVE AND DE-STIFFENING  
STRATEGIES FOR HEART FAILURE PREVENTION
Targeting the risk factors of preclinical LV remodelling and 
dysfunction may be the most cost-effective strategy to reduce 
the massive burden of HF on societal health and healthcare 
[30]. As such, BP reduction is important in primary prevention 
of symptomatic HF. Indeed, it has been shown to decrease 
the risk of HF by reversing adverse myocardial remodelling 
processes related to hypertension. For instance, Verdecchia 
et al. [70] undertook a meta-regression analysis of 31 eligible 
trials, including 225,764 patients and 6469 new cases of symp-
tomatic HF, to study the effects of antihypertensive drugs in 
the prevention of congestive HF in patients with hypertension 
or at high cardiovascular risk. Overall, the risk of new-onset 
HF significantly decreased by 24% per 5-mmHg reduction in 
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systolic BP. Moreover, BP-lowering drugs were shown to re-
duce LV mass [71] and improve LV diastolic function [72] thus 
reversing two major cardiac consequences of hypertension. 
Studies investigating sex-specific effects of anti-hypertensive 
treatment on LVH came to discrepant and inconclusive find-
ings so far [73–76]. As such, more research is required to 
elucidate a potential sex-dependent response of the heart to 
antihypertensive therapy, but optimal BP control appears to 
be an effective strategy to diminish subclinical maladaptation 
of the heart in both men and women.
As reviewed elsewhere [77, 78], antihypertensive drugs 
might also reduce arterial stiffness, especially calcium channel 
blockers and those targeting the renin-angiotensin system [79]. 
However, current non-invasive measures of arterial stiffness 
are BP-dependent, making it hard to distinguish the beneficial 
BP-lowering effects from those caused by de-stiffening of the 
arterial wall. In addition to BP-lowering drugs, statins, anti-
diabetic drugs, advanced glycation end-products, cross-link 
breakers, and anti-inflammatory drugs have been proposed 
to lower arterial stiffness, but are still under development 
or validation [80]. On the other hand, favourable effects of 
physical activity [81–85] and weight reduction [86] on arterial 
stiffness have been described in both healthy individuals and 
in patients with cardiovascular risk factors. So far, large-scale, 
long-term, randomised controlled trials remain essential to 
investigate the protective effects of pharmacological interven-
tion or lifestyle modification on arterial stiffness and, in turn, 
on (sub)clinical LV maladaptation in both men and women. 
CONCLUSIONS 
Subclinical LV abnormalities such as impaired LV longitudi-
nal deformation, diastolic dysfunction, and LVH are highly 
prevalent in the general population and predispose to car-
diovascular morbidity and mortality in both men and women. 
Hypertension and arterial stiffening initiate and accelerate the 
progression of early LV remodelling and dysfunction and, in 
the long run, contribute to the development of heart failure. 
Elevated BP and stiff arteries are important mediators of LV 
concentric remodelling and hypertrophy in both men and 
women. However, women appear to be more susceptible to 
the detrimental effects of increased pulsatile load on LV dias-
tolic function. Overall, women have a higher aortic pulsatile 
load and stiffness, enhanced LV systolic performance, and 
a lower LV compliance as compared to men, which might 
explain the female predominance in HFpEF. A comprehensive 
assessment of cardiac function and structure for risk stratifica-
tion is important in both men and women. Likewise, preven-
tive strategies such as BP control and management of arterial 
stiffness hold great potential to reduce the development and 
surging burden of HF on our society. 
Conflict of interest: none declared
Figure 5. Extrapolation from a multivariable-adjusted model of radial strain in relation to indexes of arterial stiffness at fixed 
levels of age. Radial strain increased significantly with higher central pulse pressure (PP) (A) and pulse wave velocity (PWV) (B) in 
middle-aged participants only, whereas it decreased with these indexes in subjects above 70 years old. The number at the extra-
polation line indicates the level of age. pint indicates the p-values for interaction between the arterial indexes and age. Reprodu-
ced from Cauwenberghs et al. [42] with permission
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